The Impact of Treatment Time Toxicity on Regimen Selection in Multiple Myeloma: A Single-Center Retrospective Study - PubMed
4 hours ago
- #time toxicity
- #treatment decision-making
- #multiple myeloma
- The study examined how treatment time toxicity, including commute times, affects treatment selection for patients with relapsed/refractory multiple myeloma.
- Findings revealed that longer commute times were significantly associated with a higher likelihood of receiving ixazomib, lenalidomide, and dexamethasone (IRd) therapy.
- Time burden is highlighted as a critical factor in real-world treatment decision-making, beyond just physical and financial toxicity.